Cerecor

CERC NASDAQ
5.05
-0.08
-1.56%
After Hours: 5.05 0 0.00% 16:00 06/19 EDT
Open
5.15
Prev Close
5.13
High
5.20
Low
4.930
Volume
72.60K
Avg Vol (3M)
98.22K
52 Week High
7.65
52 Week Low
2.710
% Turnover
0.17%
Market Cap
215.91M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Cerecor CERC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment. The Company owns the rights to its COMTi platform. Catechol O methyltransferase (COMT) is an enzyme critical for the inactivation and metabolism of dopamine and its inhibition in the brain has applicability in treating subjects with neuropsychiatric conditions, including MDD, schizophrenia, Parkinson's disease and pathological gambling. Its COMTi platform comprises COMT inhibitors with selectivity for membrane bound COMT, which is the dominant form of COMT.
MORE >

Recently

Name
Price
%Change